Table 2.
Comorbidities in general study population, in survived/deceased and non-ICU/ICU patient subgroups.
| n (%) | |||||||||||
| General population (n=231) | Non-ICU (n=157) | ICU (n=74) | Survived (n=101) | Deceased (n=130) | p* | ||||||
| Hypertension | 137 | 59.3% | 103 | 65.6% | 34 | 45.9% | 47 | 46.5% | 90 | 69.2% | <0.001 |
| Diabetes | 65 | 28.1% | 55 | 35% | 10 | 13.5% | 28 | 27.7% | 37 | 28.5% | 0.901 |
| Cardiac disease | 40 | 17.3% | 34 | 21.6% | 6 | 8.1% | 10 | 9.9% | 30 | 23.1% | 0.001 |
| COPD | 24 | 10.4% | 19 | 12.1% | 5 | 6.8% | 16 | 15.8% | 8 | 6.2% | 0.017 |
| Other respiratory diseases | 31 | 13.4% | 24 | 15.2% | 7 | 9.4% | 19 | 18.8% | 12 | 9.2% | OSAS: 0.865 Asthma: 0.276 |
| CKD | 8 | 3.5% | 7 | 4.5% | 1 | 1.4% | 1 | 1% | 7 | 5.4% | 0.070 |
| Liver disease | 14 | 6.1% | 10 | 6.3% | 4 | 5.6% | 5 | 5.0% | 9 | 6.9% | 0.533 |
| Vasculopathy | 9 | 3.9% | 7 | 4.5% | 2 | 2.8% | 3 | 3.0% | 6 | 4.6% | 0.522 |
| Malignancy | 13 | 5.6% | 8 | 5.1% | 5 | 6.7% | 3 | 3.0% | 10 | 7.7% | 0.122 |
| DVT/PE | 6 | 2.6% | 5 | 3.2% | 1 | 1.4% | 0 | 0.0% | 6 | 4.6% | 0.029 |
| Stroke/ TIA | 6 | 2.6% | 3 | 1.9% | 3 | 4.2% | 2 | 2.0% | 4 | 3.1% | 0.629 |
n, number; ICU, intensive care unit; Cardiac disease: structural, valvular or arrhythmic; COPD, chronic obstructive pulmonary disease; Other respiratory disease, asthma and OSAS (Obstructive Sleep Apnea Syndrome); CKD, chronic kidney disease; DVT, deep vein thrombosis; PE, pulmonary embolism; TIA, transient ischemic attack. *p value has been calculated for survived and deceased patients.